BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22713616)

  • 1. Newer anticoagulants in critically ill patients.
    Rajasekhar A; Beyth R; Crowther MA
    Crit Care Clin; 2012 Jul; 28(3):427-51, vii. PubMed ID: 22713616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.
    Schellong SM; Haas S; Greinacher A; Schwanebeck U; Sieder C; Abletshauser C; Bramlage P; Riess H
    Expert Opin Pharmacother; 2010 Dec; 11(18):2953-61. PubMed ID: 20950224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboprophylaxis in the intensive care unit: focus on medical-surgical patients.
    Cook DJ; Crowther MA
    Crit Care Med; 2010 Feb; 38(2 Suppl):S76-82. PubMed ID: 20083918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units.
    Robertson MS; Nichol AD; Higgins AM; Bailey MJ; Presneill JJ; Cooper DJ; Webb SA; McArthur C; MacIsaac CM; ;
    Crit Care Resusc; 2010 Mar; 12(1):9-15. PubMed ID: 20196708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.
    Duranteau J; Taccone FS; Verhamme P; Ageno W;
    Eur J Anaesthesiol; 2018 Feb; 35(2):142-146. PubMed ID: 29112545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism prophylaxis in critically ill patients.
    McLeod AG; Geerts W
    Crit Care Clin; 2011 Oct; 27(4):765-80, v. PubMed ID: 22082513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
    Hirsh J
    Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letters on management of ischemic stroke.
    Porat G
    Am Fam Physician; 2012 Sep; 86(6):492. PubMed ID: 23062038
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia in critically ill patients.
    Warkentin TE
    Crit Care Clin; 2011 Oct; 27(4):805-23, v. PubMed ID: 22082515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing venous thromboembolism in critically ill patients.
    Crowther MA; Cook DJ
    Semin Thromb Hemost; 2008 Jul; 34(5):469-74. PubMed ID: 18956287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in critical illness in a community intensive care unit.
    Muscedere JG; Heyland DK; Cook D
    J Crit Care; 2007 Dec; 22(4):285-9. PubMed ID: 18086398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombosis prophylaxis with heparins in intensive care patients].
    Greinacher A; Janssen D
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):156-63. PubMed ID: 15770559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study.
    Cook D; Laporta D; Skrobik Y; Peters S; Sharpe M; Murphy P; Chin D; Crowther M;
    J Crit Care; 2001 Dec; 16(4):161-6. PubMed ID: 11815901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke.
    Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD
    Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for the out-of-hospital treatment of venous thrombosis: rationale and clinical results.
    Hirsh J; Crowther M
    Thromb Haemost; 1997 Jul; 78(1):689-92. PubMed ID: 9198240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
    Welzel D; Hull R; Fareed J
    Int Angiol; 2011 Jun; 30(3):199-211. PubMed ID: 21617603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.
    Ribic C; Lim W; Cook D; Crowther M
    J Crit Care; 2009 Jun; 24(2):197-205. PubMed ID: 19327323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.